Rote-Hand-Brief: Respreeza (humaner Alpha-1-Proteinase-Inhibitor)

Imported from official source

Announcement

Safety Classified by Officially

Risiko einer Dosisauslassung und potenzieller Infektionen aufgrund einer beeinträchtigten Integrität des Primärbehältnisses

Source: Paul-Ehrlich-Institut.

Read the original at the source: https://www.pei.de/DE/newsroom/veroffentlichungen-arzneimittel/sicherheitsinformationen-human/2026/ablage2026/2026-10-30-rhb-respreeza.html

Officially imported this from Paul-Ehrlich-Institut’s own source. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization
Paul-Ehrlich-Institut — imported from official source
Official source
https://www.pei.de/SiteGlobals/Functions/RSSFeed/RSSGenerator_Sicherheitsinformationen.xml?nn=168758 RSS
Imported
October 30, 2026 11:30
Versions
1 recorded
Identity
https://www.pei.de/DE/newsroom/veroffentlichungen-arzneimittel/sicherheitsinformationen...

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.